Serina Therapeutics, Inc. Income (Loss) from Continuing Operations, Per Basic Share
Serina Therapeutics, Inc. (SER) reported Income (Loss) from Continuing Operations, Per Basic Share of -$0.28 per share for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-31.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsPerBasicShare · last filed 2023-03-31
- Serina Therapeutics, Inc. income (loss) from continuing operations, per basic share for the quarter ending 2022-09-30 was -$0.06.
- Serina Therapeutics, Inc. income (loss) from continuing operations, per basic share for the quarter ending 2022-06-30 was -$0.07.
- Serina Therapeutics, Inc. income (loss) from continuing operations, per basic share for the quarter ending 2022-03-31 was -$0.07.
- Serina Therapeutics, Inc. income (loss) from continuing operations, per basic share for the quarter ending 2021-09-30 was -$0.05.
- Serina Therapeutics, Inc. income (loss) from continuing operations, per basic share for fiscal 2022 was -$0.28.
- Serina Therapeutics, Inc. income (loss) from continuing operations, per basic share for fiscal 2021 was -$0.23.
| Period end | Income (Loss) from Continuing Operations, Per Basic Share 3 month | Income (Loss) from Continuing Operations, Per Basic Share 6 month | Income (Loss) from Continuing Operations, Per Basic Share 9 month | Income (Loss) from Continuing Operations, Per Basic Share 12 month |
|---|---|---|---|---|
| 2022-12-31 | -$0.28 10-K · filed 2023-03-31 | |||
| 2022-09-30 | -$0.06 10-Q · filed 2022-11-10 | -$0.20 10-Q · filed 2022-11-10 | ||
| 2022-06-30 | -$0.07 10-Q · filed 2022-08-12 | -$0.14 10-Q · filed 2022-08-12 | ||
| 2022-03-31 | -$0.07 10-Q · filed 2022-05-13 | |||
| 2021-12-31 | -$0.23 10-K · filed 2023-03-31 | |||
| 2021-09-30 | -$0.05 10-Q · filed 2022-11-10 | -$0.17 10-Q · filed 2022-11-10 | ||
| 2021-06-30 | -$0.07 10-Q · filed 2022-08-12 | -$0.12 10-Q · filed 2022-08-12 | ||
| 2021-03-31 | -$0.05 10-Q · filed 2022-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |